Please find below the programme. The
| Journal club – reading medical literature | |
| 1. (28.4) | Tournoij E, Peters RJG, Langenberg M, Kanhai KJK, Moll FL. The prevalence of intolerance for low-dose acetylsalicylacid in the secondary prevention of atherothrombosis. European journal of vascular and endovascular surgery . 2009;37(5):597–603. Tournoij et al. – 2009 |
| 2. (5.5) | Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. The New England journal of medicine. 2001;344(1):3–10.Sacks et al. – 2001 – |
| 3. (12.5) | Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S. Efficacy of gabapentin in migraine prophylaxis. Headache 2001; 41: 119–28.Mathew et al. – 2001 – |
| 4. (19.5) | Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1998;97(18):1837–1847.Wilson et al. – 1998 |
| 5. (27.5) | Vlak MHM, Rinkel GJE, Greebe P, van der Bom JG, Algra A. Trigger factors and their attributable risk for rupture of intracranial aneurysms: a case-crossover study. Stroke 2011;42(7):1878–82.Vlak et al. – 2011 – |
| 6. (2.6) | de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA : the journal of the American Medical Association. 2009;302(16):1782–9.de Jager et al. – 2009 – |
| 7. (9.6) | Biere-Rafi S, Hutten BA, Squizzato A, Ageno W, Souverein PC, de Boer A, Gerdes VEA, Büller HR, Kamphuisen PW. Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J 2013; .Biere-Rafi et al. – 2013 – |
| 8. (16.6) | Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. New Eng J Med. 2008;359(18):1897–908. Zacho et al. – 2008 – |
bob siegerink 